phenylephrine and kn 93
phenylephrine has been researched along with kn 93 in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Han, H; Shi, H; Wang, H; Wang, J; Wang, Z; Yang, B; Zhang, Y | 1 |
Hongo, K; Komukai, K; Kurihara, S; Kusakari, Y; O-Uchi, J; Obata, T; Sasaki, H | 1 |
Chen, SA; Chen, YC; Chen, YJ; Lin, CI; Lo, LW; Wongcharoen, W | 1 |
Other Studies
3 other study(ies) available for phenylephrine and kn 93
Article | Year |
---|---|
Different subtypes of alpha1-adrenoceptor modulate different K+ currents via different signaling pathways in canine ventricular myocytes.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Dogs; Enzyme Inhibitors; Heart; Indoles; Maleimides; Myocardium; Patch-Clamp Techniques; Phenylephrine; Piperazines; Potassium; Protein Kinase C; Receptors, Adrenergic, alpha-1; Signal Transduction; Sulfonamides | 2001 |
alpha1-adrenoceptor stimulation potentiates L-type Ca2+ current through Ca2+/calmodulin-dependent PK II (CaMKII) activation in rat ventricular myocytes.
Topics: Animals; Benzylamines; Blotting, Western; Calcium; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Heart Ventricles; Immunoblotting; Immunohistochemistry; Male; Microscopy, Fluorescence; Microscopy, Immunoelectron; Muscle Cells; Patch-Clamp Techniques; Phenylephrine; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Sulfonamides; Time Factors | 2005 |
Calmodulin kinase II inhibition prevents arrhythmic activity induced by alpha and beta adrenergic agonists in rabbit pulmonary veins.
Topics: Action Potentials; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Dose-Response Relationship, Drug; In Vitro Techniques; Isoproterenol; Kinetics; Phenylephrine; Protein Kinase Inhibitors; Pulmonary Veins; Rabbits; Sulfonamides | 2007 |